company background image

Vimian Group OM:VIMIAN Stock Report

Last Price


Market Cap







15 Aug, 2022


Company Financials +
VIMIAN fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance1/6
Financial Health2/6

VIMIAN Stock Overview

Vimian Group AB (publ) engages in the animal health business worldwide.

Vimian Group AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vimian Group
Historical stock prices
Current Share Pricekr42.80
52 Week Highkr123.40
52 Week Lowkr37.26
1 Month Change2.44%
3 Month Change-21.68%
1 Year Change-58.45%
3 Year Changen/a
5 Year Changen/a
Change since IPO-47.10%

Recent News & Updates

Jun 18
We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

May 19
Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

Does the May share price for Vimian Group AB (publ) ( STO:VIMIAN ) reflect what it's really worth? Today, we will...

Shareholder Returns

VIMIANSE Medical EquipmentSE Market

Return vs Industry: VIMIAN underperformed the Swedish Medical Equipment industry which returned -44.8% over the past year.

Return vs Market: VIMIAN underperformed the Swedish Market which returned -21.8% over the past year.

Price Volatility

Is VIMIAN's price volatile compared to industry and market?
VIMIAN volatility
VIMIAN Average Weekly Movement8.8%
Medical Equipment Industry Average Movement7.6%
Market Average Movement7.2%
10% most volatile stocks in SE Market12.6%
10% least volatile stocks in SE Market4.5%

Stable Share Price: VIMIAN is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: VIMIAN's weekly volatility (9%) has been stable over the past year.

About the Company

2020700Fredrik Ullman

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.

Vimian Group AB (publ) Fundamentals Summary

How do Vimian Group's earnings and revenue compare to its market cap?
VIMIAN fundamental statistics
Market Cap€1.56b
Earnings (TTM)€4.10m
Revenue (TTM)€197.57m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VIMIAN income statement (TTM)
Cost of Revenue€59.14m
Gross Profit€138.43m
Other Expenses€134.33m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Nov 16, 2022

Earnings per share (EPS)0.011
Gross Margin70.07%
Net Profit Margin2.07%
Debt/Equity Ratio79.3%

How did VIMIAN perform over the long term?

See historical performance and comparison